Glenmede Trust Co. NA lowered its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 1.7% in the third quarter, Holdings Channel reports. The firm owned 1,181,534 shares of the company’s stock after selling 19,954 shares during the period. Procter & Gamble makes up about 1.0% of Glenmede Trust Co. NA’s investment portfolio, making the stock its 15th biggest position. Glenmede Trust Co. NA’s holdings in Procter & Gamble were worth $204,642,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. FMR LLC raised its position in Procter & Gamble by 2.7% in the third quarter. FMR LLC now owns 26,556,319 shares of the company’s stock valued at $4,599,554,000 after purchasing an additional 689,282 shares during the period. Legal & General Group Plc raised its holdings in shares of Procter & Gamble by 0.6% during the 2nd quarter. Legal & General Group Plc now owns 21,632,054 shares of the company’s stock valued at $3,567,556,000 after buying an additional 122,190 shares during the period. Fisher Asset Management LLC lifted its position in Procter & Gamble by 4.7% during the 3rd quarter. Fisher Asset Management LLC now owns 18,380,610 shares of the company’s stock worth $3,183,522,000 after acquiring an additional 830,476 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Procter & Gamble by 0.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 16,422,470 shares of the company’s stock worth $2,844,442,000 after acquiring an additional 105,734 shares during the period. Finally, Dimensional Fund Advisors LP grew its position in Procter & Gamble by 8.2% in the second quarter. Dimensional Fund Advisors LP now owns 9,691,925 shares of the company’s stock valued at $1,598,510,000 after acquiring an additional 733,440 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on PG shares. DA Davidson raised shares of Procter & Gamble from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $160.00 to $209.00 in a research report on Monday. Piper Sandler assumed coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective for the company. Evercore ISI lifted their price objective on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. DZ Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price for the company in a research report on Thursday, August 29th. Finally, StockNews.com lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Eight investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $180.45.
Insider Activity
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the sale, the insider now directly owns 11,566 shares of the company’s stock, valued at approximately $1,954,538.34. This represents a 52.53 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Susan Street Whaley sold 634 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the transaction, the insider now directly owns 19,341 shares in the company, valued at $3,319,882.65. This represents a 3.17 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 35,233 shares of company stock worth $6,024,234 over the last three months. Corporate insiders own 0.18% of the company’s stock.
Procter & Gamble Stock Performance
PG opened at $179.31 on Wednesday. The Procter & Gamble Company has a twelve month low of $142.50 and a twelve month high of $179.46. The stock has a market cap of $422.28 billion, a PE ratio of 30.92, a price-to-earnings-growth ratio of 3.82 and a beta of 0.42. The business’s 50 day moving average is $170.11 and its 200-day moving average is $168.83. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. During the same quarter in the previous year, the firm posted $1.83 EPS. The firm’s quarterly revenue was down .6% on a year-over-year basis. On average, analysts predict that The Procter & Gamble Company will post 6.96 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.25%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s dividend payout ratio is currently 69.48%.
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 2 Generic Drug Stocks Ready to Surge in 2025
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Small-Cap Stocks That Are Ready to Rocket Higher
- Ride Out The Recession With These Dividend KingsĀ
- 2 Essential Data Center Solutions Providers Riding the AI Boom
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.